Class 1 Device Recall: Endologix AFX Device Recalled Due to Type III Endoleaks

The US Food and Drug Administration has identified this as a Class I recall, with continued device use resulting in serious injury or death.

Source link

Related posts

In This Issue: April [In This Issue: April]


Oral Anticoagulation Therapy and Progression of Calcific Aortic Valve Stenosis


Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy